Locana, Inc.
11 articles with Locana, Inc.
-
BioSpace Movers & Shakers, April 3
4/3/2020
Companies strengthen their leadership teams and executive boards with this week's Movers & Shakers. -
Locana Expands Leadership Team with Appointment of Micah Mackison, as Chief Business Officer
4/1/2020
Locana, Inc., a leading RNA-targeting gene therapy company, announced the appointment of Micah Mackison, as Chief Business Officer.
-
BioSpace Movers & Shakers, Dec. 13
12/13/2019
Pharma and biotech companies strengthen their leadership teams and boards with this week's hires. -
Locana Bio Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer
12/10/2019
Locana, Inc., a leading RNA-targeting gene therapy company, announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding the experienced leadership team and as part of a planned transition of the company’s director and recent CEO, Jeffrey M. Ostrove, Ph.D., to continue service as director..
-
Locana Expands Leadership Team with Appointment of former Casebia CEO, James Burns, Ph.D., as Chief Executive Officer
12/10/2019
Locana, Inc. announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding the experienced leadership team and as part of a planned transition of the company's director and recent CEO, Jeffrey M. Ostrove, Ph.D., to continue service as director..
-
BioSpace Movers & Shakers, Sept. 6
9/6/2019
Biopharma companies strengthen the C-suite and board of directors with these appointments. -
Locana appoints Kathie Bishop, Ph.D., as Chief Scientific Officer
9/4/2019
Locana, a leading RNA-targeting gene therapy company, today announced the appointment of Kathie M. Bishop, Ph.D. as chief scientific officer.
-
MDA Awards Venture Philanthropy Grant to Locana to Develop Novel Treatment for Muscular Dystrophy
6/12/2019
The Muscular Dystrophy Association and Locana, a leading RNA-targeting gene therapy company, announced the award of an MDA Venture Philanthropy grant totaling $550,000 to advance Locana's development program for myotonic dystrophy.
-
BioSpace Movers and Shakers, May 24
5/24/2019
Biopharma companies from across the globe strengthen their leadership teams with key executive appointments. -
San Diego-based Locana will develop RNA-targeting gene therapy programs.
-
Locana Raises $55 Million Series A Financing to Advance Portfolio of RNA-targeting Gene Therapies
5/22/2019
Locana, Inc. announced the close of a $55 million Series A financing led by ARCH Venture Partners with participation from Temasek and Lightstone Ventures, all existing investors.